《大行報告》野村下調威高股份(01066.HK)目標價至12.26元 評級「買入」
野村發表評級報告指,威高股份(01066.HK)附屬威高骨科(688161.SH)首季銷售按年下跌19.1%至3.4億元人民幣,按季則跌41.6%,威高骨科首季純利按年下跌12%至9,800萬元人民幣。報告引述管理層稱,表現呆滯主因創傷及新冠產品在省級帶量採購下降價,影響幾乎整個3月表現。管理層料4月初起情況將正常化。
該行將威高股份今年和明年收入預測下調2%及2%,各年盈測則下調3%及4%,以反映威高骨科今年首季業績,因威高骨科產品貢獻威高股份去年總收入的16%。以現金流折現率計,野村並將威高股份目標價由13.56元下調至12.26元,意味著有約47%上行空間,維持其「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.